Xolitop® Ruxolitinib Product Information Proprietary Name: Xolitop® Generic Name: Ruxolitinib Dosage Form: Topical Cream Strengths: 1.5 g/100 g Indications: Non-segmental vitiligo with facial involvement, Mild to moderate atopic dermatitis (eczema) Download Leaflet Other Products Xolitop® Ruxolitinib is indicated for the treatment of non-segmental vitiligo with facial involvement, and mild to moderate atopic dermatitis (eczema).

Mygept® Rimegepant Product Information Proprietary Name: Mygept® Generic Name: Rimegepant Dosage Form: Orally Disintegrating Tablet (ODT) Strengths: 75 mg Indications: Treat and prevent migraine attacks in adults Download Leaflet Neurology Mygept® Rimegepant is indicated for the treat and prevent migraine attacks in adults.

Trupag® Eltrombopag Product Information Proprietary Name: Trupag® Generic Name: Eltrombopag Dosage Form: Film-coated Tablet Strengths: 25 mg, 50 mg Indications: Immune thrombocytopenia (ITP), Thrombocytopenia associated with chronic hepatitis C virus (HCV) infection, Severe aplastic anemia (SAA) Download Leaflet Other Products Trupag® Eltrombopag is indicated for the treatment of immune thrombocytopenia (ITP), thrombocytopenia associated with chronic hepatitis C virus (HCV) infection, and severe aplastic anemia (SAA).

Atranel® Nelarabine Product Information Proprietary Name: Atranel® Generic Name: Nelarabine Dosage Form: Vial Strengths: 250 mg/ 50 ml Indications: T-cell acute lymphoblastic leukemia, T-cell lymphoblastic lymphoma Download Leaflet Oncology Atranel® Nelarabine is indicated for the treatment of T-cell acute lymphoblastic leukemia, T-cell lymphoblastic lymphoma.

Tedanix® Nintedanib Product Information Proprietary Name: Tedanix® Generic Name: Nintedanib Dosage Form: Soft Gelatin Capsule Strengths: 100 mg, 150 mg Indications: Idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, systemic sclerosis associated interstitial lung disease (SSc-ILD) Download Leaflet Other Products Tedanix® Nintedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with...

Etoraz® Etoposide Product Information Proprietary Name: Etoraz® Generic Name: Etoposide Dosage Form: Vial Strengths: 100 mg/5 ml, 200 mg/10 ml Indications: Cancers such as testicular cancer, Small-cell lung cancer, Blood cancer, Tumor in the lymphatic system and reproductive system cancers Download Leaflet Oncology Etoraz® Etoposide is indicated for the treatment of cancers such as testicular cancer, small-cell lung cancer, blood cancer, tumor in the lymphatic system and reproductive system cancers.

Parzino® Olaparib Product Information Proprietary Name: Parzino® Generic Name: Olaparib Dosage Form: Film-coated Tablet Strengths: 100 mg, 150 mg Indications: Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer Download Leaflet Oncology Parzino® Olaparib is indicated for the treatment of patients with ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.

پارزینو® الاپاریب مشخصات محصول نام تجاری: پارزینو® نام ژنریک: الاپاریب شکل دارو: قرص روکش‌دار دوزهای دارو: ۱۰۰ میلی‌گرم و ۱۵۰ میلی‌گرم موارد مصرف: درمان سرطان رحم، سرطان پستان، سرطان پانکراس و سرطان پروستات دانلود بروشور انکولوژی پارزینو® الاپاریب در درمان سرطان رحم، سرطان پستان، سرطان پانکراس و سرطان پروستات کاربرد دارد.

سایر محصولات گانسیکلوویر ۵۰۰ گانسیکلوویر تروپگ الترومبوپگ زولیتاپ روکسولیتینیب ولوسیا اوزانیمود مرولیک مایکوفنولیک اسید لیراتان ماسیتنتان ساپروتاک تاکرولیموس رولیما اورولیموس ریکانزا وریکونازول لتوکان کسپوفونژین استات پیکسانا پوساکونازول